Veru Survey Highlights Muscle Loss Concerns Among GLP-1 Users as Lean Mass-Preserving Drug Advances on July 15, 2025 agonists Diet, High-Protein Elderly (population group) enobosarm GLP-1 receptor Lean Mass muscle loss Obesity Surveys Veru +
Scholar Rock's SMA drug helps Zepbound patients retain muscle in phase 2 trial on June 18, 2025 apitegromab GDF8 protein, human Inhibitor Lean Mass muscle preservation Obesity Phase 2 trial Scholar Rock Spinal Muscular Atrophy Weight Loss Zepbound +